Shire to Participate at the Cowen 37th Annual Healthcare Conference

Wednesday, March 1, 2017 General News J E 4

LEXINGTON, Massachusetts, March 1, 2017 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Jeff Poulton, Chief Financial Officer, will participate at the Cowen 37th Annual Healthcare Conference in Boston, MA on Monday, March 6, 2017 at 1:20 p.m. ET (18:20 GMT).

A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.


About Shire 

Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

For further information please contact: Investor Relations Ian Karp +1-781-482-9018

Robert Coates +44-1256-894874

SOURCE Shire plc



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Revenue Cycle and Coding Strategies Merge to Expan...
Check-Cap to Present at the 29th Annual ROTH Confe...